MNBTD
PCRX icon

Moody National Bank Trust Division’s Pacira BioSciences PCRX Stock Holding History

Moody National Bank Trust Division’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-89
Closed -$4K – 1337
2018
Q4 		$4K Buy
+89
New +$4.15K ﹤0.01% 978

Other funds holding PCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Frontier Capital Management
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Stephens Investment Management Group
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Moody National Bank Trust Division's PCRX Position: Q1 2019 in Review

Moody National Bank Trust Division sold out of Pacira BioSciences (PCRX) in Q1 2019, closing a stake of 89 shares — an estimated $4K sold.

Moody National Bank Trust Division first reported a position in PCRX in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 210 funds tracked by Wall St. Rank hold PCRX as of Q1 2019.

  • Moody National Bank Trust Division reported no remaining Pacira BioSciences position as of Q1 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 89 Pacira BioSciences shares in Q1 2019, an estimated $4K.
  • Moody National Bank Trust Division first reported a position in Pacira BioSciences in Q4 2018 and held it in 1 quarter.
  • Moody National Bank Trust Division's Pacira BioSciences position peaked at $4K in Q4 2018.
  • 210 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2019.

Based on Moody National Bank Trust Division's 13F filing for Q1 2019, filed 11 Apr 2019.